Review article| Open access | J Adv Biotechnol Exp Ther. 2025; 8(2): 283-300|doi: 10.5455/jabet.2025.24

Animal model-based adjunctive herbal therapy in autism spectrum disorder: Therapeutic advances and prospects

Abstract

Autism spectrum disorder is a complex neurodevelopmental condition that poses major challenges to caregivers in contemporary societies. Since there is no established cure for this disorder so far, autistic patients of all ages are currently taken in charge of psychological and educational therapies that address their primary complaints while enhancing their quality of life. With the growing interest in herbal therapy globally, especially for illnesses with well-known underlying mechanisms, there have been clinical attempts to treat autism symptomatology using herbs or natural plant molecules in parallel with traditional follow-up. Nevertheless, basic research has only recently focused on studying the effects of herbal extracts in animal models of autism. This review emphasizes the animal studies that may provide credence to the adjunction of herbal therapy to conventional care strategies. Therefore, the study deduced a timeline chart combining promising herbal extracts such as Camellia sinensis, Bacopa monniera, and Korean red ginseng. This allows clinicians and caregivers to further evaluate the positive outcomes reported in autistic-like rodents. In conclusion, the study suggests employing herbal therapy as a clinical adjunct in the context of phytosupportive care.

References

  • [1]Zeidan J, Fombonne E, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022;15(5):778-790.
  • [2]Okoye C, Obialo-Ibeawuchi CM, et al. Early diagnosis of autism spectrum disorder: A review and analysis of the risks and benefits. Cureus. 2023;15(8):e43226.
  • [3]Mutluer T, Aslan Genç H, et al. Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: A meta-analysis. Front Psychiatry. 2022;13.
  • [4]Hellings J. Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials. World J Psychiatry. 2023;13(6):262-277.
  • [5]Turner M. The role of drugs in the treatment of autism. Aust Prescr. 2020;43(6):185-190.
  • [6]Hannan MA, Zahan MS, et al. Protective Effects of Black Cumin (Nigella sativa) and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights. Int J Mol Sci. 2021;22(16):9078.
  • [7]Rahman MA, Rahman MH, et al. Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease. Antioxidants. 2021;10(1):23.
  • [8]Bhakta S, Awal A, et al. Herbal contraceptive effect of Abrus precatorius, Ricinus communis, and Syzygium aromaticum on anatomy of the testis of male Swiss albino mice. J Adv Biotechnol Exp Ther. 2019;2(2):36-43.
  • [9]Tang SW, Tang WH, et al. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature. World J Biol Psychiatry. 2019;20(8):586-604.
  • [10]Lewis WH, Elvin-Lewis MPF. Medical Botany: Plants Affecting Human Health. 2nd Ed. Wiley: NJ, USA, 2003.
  • [11]Malaguarnera M, Khan H, et al. Resveratrol in autism spectrum disorders: Behavioral and molecular effects. Antioxidants (Basel). 2020;9(3):188.
  • [12]Magner M, Thorová K, et al. Sulforaphane treatment in children with autism: A prospective randomized double-blind study. Nutrients. 2023;15(3):718.
  • [13]Cangialose A, Allen PJ. Screening for autism spectrum disorders in infants before 18 months of age. Pediatr Nurs. 2014;40(1):33-37.
  • [14]Waizbard-Bartov E, Fein D, et al. Autism severity and its relationship to disability. Autism Res. 2023;16(4):685-696.
  • [15]Parmeggiani A, Corinaldesi A, et al. Early features of autism spectrum disorder: a cross-sectional study. Ital J Pediatr. 2019;45(1).
  • [16]Baweja R, Waschbusch DA, et al. Physical aggression toward others and self: Correlates in autism, attention-deficit/hyperactivity disorder, and population-based child samples. JAACAP Open. 2023;1(4):274-283.
  • [17]Linke AC, Olson L, et al. Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(6):518-527.
  • [18]Estancial Fernandes CS, de Azevedo RCS, et al. Psychotropic use patterns: Are there differences between men and women? PLoS One. 2018;13(11):e0207921.
  • [19]Niederhofer H. First preliminary results of an observation of Ginkgo Biloba treating patients with autistic disorder. Phytother Res. 2009;23(11):1645-1646.
  • [20]Niederhofer H. St John’s Wort treating patients with autistic disorder. Phytother Res. 2009;23(11):1521-1523.
  • [21]Hasanzadeh E, Mohammadi MR, et al. A double-blind placebo controlled trial of ginkgo biloba added to risperidone in patients with autistic disorders. Child Psychiatry Hum Dev. 2012;43(5):674-682.
  • [22]Banerjee U, Izquierdo JA. Antistress and antifatigue properties of Panax ginseng: comparison with piracetam. Acta Physiol Lat Am. 1982;32(4):277-285.
  • [23]Niederhofer H. First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder. J Diet Suppl. 2009;6(4):342-346.
  • [24]Singh K, Connors SL, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014;111(43):15550-15555.
  • [25]Bang M, Lee SH, et al. Herbal medicine treatment for children with autism spectrum disorder: A systematic review. Evid Based Complement Alternat Med. 2017;2017(1).
  • [26]Lázaro MT, Golshani P. The utility of rodent models of autism spectrum disorders. Curr Opin Neurol. 2015;28(2):103-109.
  • [27]Banji D, Banji OJF, et al. Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res. 2011;1410:141-151.
  • [28]Salem FEH, Abdel-Gaber R, et al. Therapeutic potency of Camellia sinensis extract on neurochemical and oxidative changes correlates to autistic disorder in rat pups model. Indian J Anim Res. 2023;57(12):1652-1661.
  • [29]Sandhya T, Sowjanya J, et al. Bacopa monniera (L.) wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res. 2012;37(5):1121-1131.
  • [30]Abhishek M, Rubal S, et al. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats. J Ethnopharmacol. 2022;293(115199):115199.
  • [31]Joon P, Dhingra D, et al. Biochemical evidence for anti-autistic potential of Asparagus racemosus. Int J Plant Sci. 2020;15(1):42-51.
  • [32]Gonzales ELT, Jang JH, et al. Supplementation of Korean Red Ginseng improves behavior deviations in animal models of autism. Food Nutr Res. 2016;60(1):29245.
  • [33]Kim P, Park JH, et al. Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid. Food Chem Toxicol. 2013;51:288-296.
  • [34]Morakotsriwan N, Wattanathorn J, et al. Autistic‐like behaviors, oxidative stress status, and histopathological changes in cerebellum of valproic acid rat model of autism are improved by the combined extract of purple rice and silkworm pupae. Oxid Med Cell Longev. 2016;2016(1).
  • [35]Wattanathorn J, Klongrum J, et al. Morus alba leaves extract improves memory impairment, oxidative stress and neurodegeneration in hippocampus of the VPA-rat model of autism. J Med Assoc Thai. 2020;103(Suppl.1):97-104.
  • [36]Saadat M, Taherian AA, et al. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain Behav. 2023;13(11).
  • [37]Amini F, Amini-Khoei H, et al. Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism. J Tradit Complement Med. 2023;13(4):315-324.
  • [38]Tejano AC, Sula-David LF, et al. Amelioration of motor behavioral aberrations and cerebellar abnormalities by ethanol leaf extract of balakat tree (Ziziphus talanai (Blanco) Merr.) in valproic acid mice model of autism. Pharm Sci Asia. 2020;47(4):329-339.
  • [39]Al-Gholam MA, Ameen O. The neuroprotective effect of Ginkgo biloba extract on valproic acid induced autistic features in mice. J Clin Diagn Res. 2020;14(8):KF01-KF06.
  • [40]Jiji KN, Muralidharan P. Neuroprotective effects of Clitoria ternatea L. against propionic acid-induced behavior and memory impairment in autistic rat model. Futur J Pharm Sci. 2021;7(1).
  • [41]Usui N, Kobayashi H, et al. Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder. Int J Mol Sci. 2023;24(6):5487.
  • [42]Ghasemi A, Jeddi S, et al. The laboratory rat: Age and body weight matter. EXCLI J. 2021;20:1431-1445.
  • [43]WHO (2010). Regional Office for South-East Asia, Traditional herbal remedies for primary health care. Available at: https://iris.who.int/handle/10665/206024/
  • [44]Smith T. Discrete trial training in the treatment of autism. Focus Autism Other Dev Disabl. 2001;16(2):86-92.
  • [45]Duifhuis EA, den Boer JC, et al. The effect of pivotal response treatment in children with autism spectrum disorders: A non-randomized study with a blinded outcome measure. J Autism Dev Disord. 2017;47(2):231-242.
  • [46]Blackwell W, Stockall N. Incidental teaching of conversational skills for students with autism spectrum disorder. Teach Except Child. 2021;54(2):116-123.
  • [47]Reichow B, Hume K, et al. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Libr. 2018;2018(10).
  • [48]Konstantinidou I, Dillenburger K, et al. Positive behaviour support: a systematic literature review of the effect of staff training and organisational behaviour management. Int J Dev Disabil. 2023;69(1):29-44.
  • [49]Nicolosi M, Dillenburger K. The University of California at Los Angeles‐Young Autism Project: A systematic review of replication studies. Behav Interv. 2022;37(2):415-464.
  • [50]Fuller EA, Oliver K, et al. The effects of the Early Start Denver Model for children with autism spectrum disorder: A meta-analysis. Brain Sci. 2020;10(6):368.
  • [51]Zhou K, Liu X, et al. The use of Treatment and Education of Autistic and Related Communication Handicapped Children in schools to improve the ability of children with autism to complete tasks independently: A single‐case meta‐analysis. Child Care Health Dev. 2024;50(2).
  • [52]Yi J, Kim W, et al. Effectiveness of the SCERTS Model–based interventions for autistic children: A systematic review. J Speech Lang Hear Res. 2022;65(7):2662-2676.
  • [53]Malhotra S, Rajender G, et al. Effects of picture exchange communication system on communication and behavioral anomalies in autism. Indian J Psychol Med. 2010;32(2):141-143.
  • [54]Divya KY, Begum F, et al. DIR/floor time in engaging autism: A systematic review. Iran J Nurs Midwifery Res. 2023;28(2):132-138.
  • [55]Gutstein SE, Burgess AF, et al. Evaluation of the Relationship Development Intervention program. Autism. 2007;11(5):397-411.
  • [56]Randell E, McNamara R, et al. Sensory integration therapy versus usual care for sensory processing difficulties in autism spectrum disorder in children: study protocol for a pragmatic randomised controlled trial. Trials. 2019;20(1).
  • [57]Hanley GP, Iwata BA, et al. Functional analysis of problem behavior: A review. J Appl Behav Anal. 2003;36(2):147-185.
  • [58]Campbell P, Rooney S, et al. Speech and language therapy interventions for speech problems in Parkinson’s disease. Cochrane Libr. 2022;2022(6).
  • [59]Bitu Pinto N, da Silva Alexandre B, et al. Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease. Evid Based Complement Alternat Med. 2015;2015:161092.
  • [60]Shinomol GK, Muralidhara, et al. Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy. Recent Pat Endocr Metab Immune Drug Discov. 2011;5(1):33-49.
  • [61]Mathew J, Gangadharan G, et al. Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri. Neurochem Res. 2011;36(1):7-16.
  • [62]Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313-326.
  • [63]Pahwa P, Goel RK. Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazol-induced kindling and associated depression and memory deficit. Epilepsy Behav. 2016;57(Pt A):196-201.
  • [64]Lalert L, Kruevaisayawan H, et al. Neuroprotective effect of Asparagus racemosus root extract via the enhancement of brain-derived neurotrophic factor and estrogen receptor in ovariectomized rats. J Ethnopharmacol. 2018;225:336-341.
  • [65]Iqbal H, Kim SK, et al. Korean Red Ginseng alleviates neuroinflammation and promotes cell survival in the intermittent heat stress-induced rat brain by suppressing oxidative stress via estrogen receptor beta and brain-derived neurotrophic factor upregulation. J Ginseng Res. 2020;44(4):593-602.
  • [66]Choi JH, Lee MJ, et al. Panax ginseng exerts antidepressant-like effects by suppressing neuroinflammatory response and upregulating nuclear factor erythroid 2 related factor 2 signaling in the amygdala. J Ginseng Res. 2018;42(1):107-115.
  • [67]Chou TW, Huang HS, et al. Korean red ginseng water extract produces antidepressant-like effects through involving monoamines and brain-derived neurotrophic factor in rats. J Ginseng Res. 2023;47(4):552-560.
  • [68]Rungratanawanich W, Cenini G, et al. γ-Oryzanol Improves Cognitive Function and Modulates Hippocampal Proteome in Mice. Nutrients. 2019;11(4):753.
  • [69]Gupta G, Afzal M, et al. Anticonvulsant activity of Morus alba and its effect on brain gamma-aminobutyric acid level in rats. Pharmacognosy Res. 2014;6(2):188-189.
  • [70]Gupta G, Dua K, et al. Anticonvulsant activity of Morusin isolated from Morus alba: Modulation of GABA receptor. Biomed Aging Pathol. 2014;4:29–32.
  • [71]Sadraei H, Shokoohinia Y, et al. Antispasmodic effects of Prangos ferulacea acetone extract and its main component osthole on ileum contraction. Res Pharm Sci. 2013;8(2):137-144.
  • [72]Zizzo MG, Cicio A, et al. Essential oil of Sicilian Prangos ferulacea (L.) Lindl. and its major component, β-ocimen, affect contractility in rat small and large intestine. J Ethnopharmacol. 2023;313:116531.
  • [73]Grundmann O, Wang J, et al. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med. 2008;74(15):1769-1773.
  • [74]Yoshitake T, Yoshitake S, et al. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol. 2010;159(3):659-668.
  • [75]Damodaran T, Cheah PS, et al. The nootropic and anticholinesterase activities of Clitoria ternatea Linn. root extract: Potential treatment for cognitive decline. Neurochem Int. 2020;139:104785.

Article Info

Academic Editor

Md. Abdul Hannan, PhD; Bangladesh Agricultural University, Bangladesh
Received
19 January, 2025
Accepted
16 March, 2025
Published
22 March, 2025

Coresponding author

Mohamed Lamine Toumi, Laboratory of Functional and Evolutionary Ecology, Department of Biology, Faculty of Natural and Life Sciences, Chadli Bendjedid University, El-Tarf, Algeria. Email: toumi-mhd-lamine@univ-eltarf.dz

Cite this article

Toumi ML,Merzoug S, et al. Animal model-based adjunctive herbal therapy in autism spectrum disorder: Therapeutic advances and prospects. J Adv Biotechnol Exp Ther. 2025; 8(2): 283-300.